Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.210
+0.120 (3.88%)
At close: Apr 13, 2026, 4:00 PM EDT
3.750
+0.540 (16.82%)
After-hours: Apr 13, 2026, 4:34 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $855.31 million as of April 13, 2026. Its market cap has increased by 110.00% in one year.
Market Cap
855.31M
Enterprise Value
808.53M
1-Year Change
110.00%
Ranking
Category
Stock Price
$3.21
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $855.31M, a decrease of -35.45%. That is a compound annual growth rate of -8.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 824.62M | -23.94% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 858.33M |
| SELLAS Life Sciences Group | 854.81M |
| Theravance Biopharma | 841.91M |
| Vor Biopharma | 838.25M |
| Omeros | 827.24M |
| Bright Minds Biosciences | 818.66M |
| Arbutus Biopharma | 811.23M |
| ARS Pharmaceuticals | 799.34M |